Navigation Links
Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference
Date:11/20/2012

SAN DIEGO, Nov. 20, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 24th Annual Piper Jaffray Healthcare Conference in New York.

The live presentation takes place on Tuesday, November 27 at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or ir@neurocrine.com.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neurocrine Biosciences Reports Third Quarter 2012 Results
2. Neurocrine Biosciences Reports Second Quarter 2012 Results
3. Neurocrine Biosciences to Present at The 24th Annual Roth Conference
4. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
5. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
6. Amarantus BioSciences Wins MANF Patent Challenge in Europe
7. Amarantus BioSciences Issues CEO Letter to Shareholders
8. Amarantus BioSciences Secures $1.1 Million in Financing
9. IntelliCell BioSciences Announces It Will Present and Run Workshop at the 10th Annual Commercialization of Regenerative Medicine in London
10. Correction: Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
11. Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... - Sales in the First Half of 2009 (Excluding ... - Growth in the Pharma Business, - ... Laboratory Glassware, , In the first ... the continuing worldwide economic crisis. This result was,mainly attributable to sales growth ...
... Mass., July 14 Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX ... the second quarter of 2009 on Monday, July 20, 2009 after ... In conjunction with the issuance of the press release, Idenix management ... July 20, 2009 to discuss the company,s financial results for the ...
... , LAKE ZURICH, Ill., July 14 ... blood collection, separation, safety and availability, announced today it has ... to market, sell and distribute Verax,s unique PanGenera(R) Detection (PGD) ... in donated blood platelets. , ...
Cached Biology Technology:Gerresheimer Holds its own in Difficult Environment 2Gerresheimer Holds its own in Difficult Environment 3Gerresheimer Holds its own in Difficult Environment 4Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test 2Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test 3
(Date:4/15/2014)... viral diseases in the world for which no pharmaceutical ... is spread by mosquitoes in the tropics, as well ... in Finland and is easily spread by the hands ... the elderly. , Researchers at Aalto University and the ... tests to prevent the spread of one type of ...
(Date:4/15/2014)... cell systems soon could be powering the forklifts used ... and with faster refueling times than ever before, courtesy ... Hydrogen Carriers (HHC). , The goal of the project ... can refuel at low pressure four to five times ... giving hydrogen a competitive advantage over batteries for a ...
(Date:4/14/2014)... swallow, but if you,re over 24 years of age ... cognitive motor performance, according to a new Simon Fraser ... doctoral student, associate professor Mark Blair, Thompson,s thesis supervisor, ... student, deliver the news in a just-published PLOS ... the first social science experiments to rest on big ...
Breaking Biology News(10 mins):Nanocrystalline cellulose modified into an efficient viral inhibitor 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 3Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 4Study says we're over the hill at 24 2
... (SACRAMENTO, Calif.) An international team of scientists led by ... cells is not a one-way street as previously believed. Their ... has a self-correcting mechanism that allows DNA to make a ... appear in the Oct. 23 online issue of the journal ...
... A peer-reviewed study commissioned by NOAA shows the American people ... the coral reefs of the main Hawaiian Islands. ... treasure Hawaii,s coral reefs, even though many never get to ... for oceans and atmosphere and NOAA administrator. "It illustrates the ...
... of Plant Biologists (ASPB) has named 12 plant biology researchers ... Science Master Plant Science Team (MPST). ... research resource that brings together middle and high school students, ... engage in hands-on plant investigations while working with peers at ...
Cached Biology News:UC Davis researchers discover complexities of DNA repair 2US residents say Hawaii's coral reef ecosystems worth $33.57 billion per year 2American Society of Plant Biologists supports science outreach by grad students and postdocs 2American Society of Plant Biologists supports science outreach by grad students and postdocs 3
Mouse polyclonal antibody raised against a partial recombinant WRB. NCBI Entrez Gene ID = 7485...
...
Mouse monoclonal to Casein Kinase 2 beta ( Abpromise for all tested applications). entrezGeneID: 1460 SwissProtID: P13862...
Mouse monoclonal antibody raised against a partial recombinant FAAH. NCBI Entrez Gene ID = FAAH...
Biology Products: